Latest debt-to-equity ratio
Aclaris Therapeutics Debt-to-equity ratio
Direct answer
Aclaris Therapeutics's debt-to-equity ratio is 1.49%.
The verified market snapshot reports 1.49%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 1.49%
Explore related company data
View Aclaris Therapeutics's market capitalizationView Aclaris Therapeutics's price-to-book ratioView Aclaris Therapeutics's return on equityView Aclaris Therapeutics's dividend yieldView Aclaris Therapeutics's 52-week price rangeView Aclaris Therapeutics's revenue growthView Aclaris Therapeutics's profit marginView all Aclaris Therapeutics key metricsReturn to Aclaris Therapeutics profile